| Autor: |
Aslihan Okan Ibiloglu, Abdullah Atli, Mehmet Gunes |
| Jazyk: |
English<br />Turkish |
| Rok vydání: |
2017 |
| Předmět: |
|
| Zdroj: |
Psikiyatride Güncel Yaklaşımlar, Vol 9, Iss 3, Pp 317-328 (2017) |
| Druh dokumentu: |
article |
| ISSN: |
1309-0674 |
| DOI: |
10.18863/pgy.270396 |
| Popis: |
Synthetic cannabinoids which is a subgroup of cannabinoids are commonly used for recreational drug use throughout the whole world. Although both marijuana and synthetic cannabinoids stimulate the same receptors, cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2), studies have shown that synthetic cannabinoids are much more potent than marijuana. The longer use of synthetic cannabinoids can cause severe physical and psychological symptoms that might even result in death, similar to many known illicit drugs. Main treatment options mostly involve symptom management and supportive care. The aim of this article is to discuss clinical and pharmacological properties of the increasingly used synthetic cannabinoids. [Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry 2017; 9(3.000): 317-328] |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
